olopatadine hydrochloride ophthalmic solution

Generic: olopatadine hydrochloride ophthalmic

Labeler: chain drug marketing association inc
NDC Directory HUMAN OTC DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name olopatadine hydrochloride ophthalmic solution
Generic Name olopatadine hydrochloride ophthalmic
Labeler chain drug marketing association inc
Dosage Form SOLUTION
Routes
OPHTHALMIC
Active Ingredients

olopatadine hydrochloride 2 mg/mL

Manufacturer
Chain Drug Marketing Association INC

Identifiers & Regulatory

Product NDC 63868-821
Product ID 63868-821_e9018310-14d0-1f1e-7bc1-c5ba9d88696b
Product Type HUMAN OTC DRUG
Marketing Category ANDA
Application Number ANDA209752
Listing Expiration 2026-12-31
Marketing Start 2021-01-01

Pharmacologic Class

Classes
decreased histamine release [pe] histamine h1 receptor antagonists [moa] histamine-1 receptor antagonist [epc] histamine-1 receptor inhibitor [epc] mast cell stabilizer [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 63868821
Hyphenated Format 63868-821

Supplemental Identifiers

RxCUI
1111343
UNII
2XG66W44KF

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name olopatadine hydrochloride ophthalmic solution (source: ndc)
Generic Name olopatadine hydrochloride ophthalmic (source: ndc)
Application Number ANDA209752 (source: ndc)
Routes
OPHTHALMIC
source: ndc

Resolved Composition

Strengths
  • 2 mg/mL
source: ndc
Packaging
  • 1 BOTTLE, PLASTIC in 1 CARTON (63868-821-25) / 2.5 mL in 1 BOTTLE, PLASTIC
source: ndc

Packages (1)

63868-821-25 1 BOTTLE, PLASTIC in 1 CARTON (63868-821-25) / 2.5 mL in 1 BOTTLE, PLASTIC

Ingredients (1)

olopatadine hydrochloride (2 mg/mL)

Linked Drug Pages (1)

Olopatadine Hydrochloride Ophthalmic Solution ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["OPHTHALMIC"], "spl_id": "e9018310-14d0-1f1e-7bc1-c5ba9d88696b", "openfda": {"unii": ["2XG66W44KF"], "rxcui": ["1111343"], "spl_set_id": ["f6d70b01-941b-b796-ceee-7f24b6038e7d"], "manufacturer_name": ["Chain Drug Marketing Association INC"]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, PLASTIC in 1 CARTON (63868-821-25)  / 2.5 mL in 1 BOTTLE, PLASTIC", "package_ndc": "63868-821-25", "marketing_start_date": "20210101"}], "brand_name": "Olopatadine Hydrochloride Ophthalmic Solution", "product_id": "63868-821_e9018310-14d0-1f1e-7bc1-c5ba9d88696b", "dosage_form": "SOLUTION", "pharm_class": ["Decreased Histamine Release [PE]", "Histamine H1 Receptor Antagonists [MoA]", "Histamine-1 Receptor Antagonist [EPC]", "Histamine-1 Receptor Inhibitor [EPC]", "Mast Cell Stabilizer [EPC]"], "product_ndc": "63868-821", "generic_name": "Olopatadine Hydrochloride Ophthalmic", "labeler_name": "Chain Drug Marketing Association INC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Olopatadine Hydrochloride Ophthalmic Solution", "active_ingredients": [{"name": "OLOPATADINE HYDROCHLORIDE", "strength": "2 mg/mL"}], "application_number": "ANDA209752", "marketing_category": "ANDA", "marketing_start_date": "20210101", "listing_expiration_date": "20261231"}